Decay variance is not approved for clinical use. It is currently only offered in a research setting.
We are not actively seeking investors at this stage, however we are willing to answer any enquiries.
Please contact us to discuss licencing arrangements. Licencing for public universities and not-for-profit institutes is generally available without charge for bona fide projects. Evidence of appropriate ethics approvals must be provided for research involving humans or animals.
Licencing to for-profit companies is generally only available on a commercial basis.
The algorithm and technical performance characteristics can be found here: https://onlinelibrary.wiley.com/doi/full/10.1002/jsp2.1060
Decay variance has been tested on a range of field strengths from 3T to 7T. Current validation research includes 1.5T scanners but these results are not yet available. So far Decay Variance has been used with Siemens, Philips and Bruker scanners. Generally any scanner able to perform a CPMG type multi-echo sequence and able to output data in a standard format (such as DICOM) should be adequate.
Decay Variance does not have regulatory approval for clinical use in humans in any country. It is currently only offered in the setting of regulated clinical studies and clinical trials.
Merunova Suite 6/B 22 Belgrave St Kogarah, NSW 2217 AU
Copyright © 2019-2020 Merunova - All Rights Reserved.